Francis E. O'Donnell
Board Member
Inhibitor Therapeutics, Inc. (INTI)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Francis E. O'Donnell
Francis E. O'Donnell is recorded as CEO and Board Member at Inhibitor Therapeutics, Inc. (INTI). Inhibitor Therapeutics, Inc. reported in an 8-K filed September 18, 2026 that Francis E. O'Donnell was appointed Director, effective September 15, 2026. The proxy statement of Inhibitor Therapeutics, Inc. reports total compensation of $1,118,630 for Francis E. O'Donnell in fiscal 2025, including a base salary of $598,000. Disclosed compensation is on record for 2 fiscal years.
“Francis E. O'Donnell, Samuel J. Sears, Niraj Vasisht, Michelle Yanez, Michael Jerman and Ronald E. Osman were each elected to serve on the Board of Directors (the "Board") for a one-year term that expires at the 2027 Annual Meeting of Stockholders, or until their earlier death, resignation or removal and their successors are elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-09-15–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Inhibitor Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Francis E. O'Donnell, Jr. CEO, Chairman
- Francis E. O'Donnell, Jr., M.D. CEO, Chairman
- James A. McNulty CFO
- James A. McNulty, CPA CFO
- Michael Jerman Board Member
- Michael Jerman, CPA. Board Member
- Michelle Yanez Board Member
- Michelle Yanez, MBA Board Member
- Niraj Vasisht Board Member
- Niraj Vasisht, Ph.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Inhibitor Therapeutics, Inc. (INTI) | Executive Chairman and Chief Executive Officer | $598,000 | $1,118,630 |
| 2024 | Inhibitor Therapeutics, Inc. (INTI) | Executive Chairman and Chief Executive Officer | $598,000 | $1,137,886 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.